GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) » Definitions » EV-to-FCF

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) EV-to-FCF : 5.30 (As of May. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wuhan Easy Diagnosis Biomedicine Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Wuhan Easy Diagnosis Biomedicine Co's Enterprise Value is ¥3,336.1 Mil. Wuhan Easy Diagnosis Biomedicine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥629.7 Mil. Therefore, Wuhan Easy Diagnosis Biomedicine Co's EV-to-FCF for today is 5.30.

The historical rank and industry rank for Wuhan Easy Diagnosis Biomedicine Co's EV-to-FCF or its related term are showing as below:

SZSE:002932' s EV-to-FCF Range Over the Past 10 Years
Min: -10064.52   Med: 6.44   Max: 2348.28
Current: 5.64

During the past 13 years, the highest EV-to-FCF of Wuhan Easy Diagnosis Biomedicine Co was 2348.28. The lowest was -10064.52. And the median was 6.44.

SZSE:002932's EV-to-FCF is ranked better than
86.59% of 358 companies
in the Medical Devices & Instruments industry
Industry Median: 29.28 vs SZSE:002932: 5.64

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-24), Wuhan Easy Diagnosis Biomedicine Co's stock price is ¥18.99. Wuhan Easy Diagnosis Biomedicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.140. Therefore, Wuhan Easy Diagnosis Biomedicine Co's PE Ratio for today is 135.64.


Wuhan Easy Diagnosis Biomedicine Co EV-to-FCF Historical Data

The historical data trend for Wuhan Easy Diagnosis Biomedicine Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Easy Diagnosis Biomedicine Co EV-to-FCF Chart

Wuhan Easy Diagnosis Biomedicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -216.51 10.99 5.84 1.33 15.99

Wuhan Easy Diagnosis Biomedicine Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.57 1.68 1.70 15.99 6.74

Competitive Comparison of Wuhan Easy Diagnosis Biomedicine Co's EV-to-FCF

For the Medical Devices subindustry, Wuhan Easy Diagnosis Biomedicine Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Easy Diagnosis Biomedicine Co's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wuhan Easy Diagnosis Biomedicine Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Wuhan Easy Diagnosis Biomedicine Co's EV-to-FCF falls into.



Wuhan Easy Diagnosis Biomedicine Co EV-to-FCF Calculation

Wuhan Easy Diagnosis Biomedicine Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3336.074/629.729
=5.30

Wuhan Easy Diagnosis Biomedicine Co's current Enterprise Value is ¥3,336.1 Mil.
Wuhan Easy Diagnosis Biomedicine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥629.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuhan Easy Diagnosis Biomedicine Co  (SZSE:002932) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Wuhan Easy Diagnosis Biomedicine Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=18.99/0.140
=135.64

Wuhan Easy Diagnosis Biomedicine Co's share price for today is ¥18.99.
Wuhan Easy Diagnosis Biomedicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.140.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Wuhan Easy Diagnosis Biomedicine Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Wuhan Easy Diagnosis Biomedicine Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Dongxin Road, 2 Floor, Building E, International Students Pioneer Park, Guandong Science and Technology Park, Donghu Development Zone, Hubei, Wuhan, CHN, 430075
Wuhan Easy Diagnosis Biomedicine Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents and supporting instruments and mobile ECG products. The company's product profile consists of Molecular diagnosis, Chemiluminescence, Blood gas analysis, and others. It also provides various other solutions such as Mingde Biomolecular Diagnostic Service Solution, Mingde Biothoracic Center Solution, POCT Solution, Remote ECG network construction solution, and others.
Executives
Wang Rui Directors, executives
Wang Jian Fei Director

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Headlines

No Headlines